Article citationsMore>>

Costa, M.A., Carere, R.G., Lichtenstein, S.V., Foley, D.P., de Valk, V., Lindenboom, W., et al. (2001) Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation, 104, 2689-2693.
http://dx.doi.org/10.1161/hc4701.099789

has been cited by the following article:

• TITLE: Tepid antegrade intermittent blood cardioplegia as an alternative for intermittent crossclamping with Lidoflazine

  AUTHORS: Sofia Kalantary, Anouk de Bruyn, Steven Laga, Inez Rodrigus

  KEYWORDS: Blood Cardioplegia; Intermittent Cross Clamping; Lidoflazine; Myocardial Protection

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.3 No.7, October 14, 2013

  ABSTRACT: Background: Blood cardioplegia is a technique with many variations in its use. Intermittent cross clamping with Lidoflazine has proven to deliver good cardioprotection in our center. Question: Is tepid (32°C) antegrade intermittent blood cardioplegia an efficient, safe and easy-to-use alternative to intermittent cross-clamping with Lidoflazine in elective isolated CABG in low-risk patients? Primary outcomes are heart enzymes (cTnI, CK-MB). Secondary outcomes are operation times, length of hospital stay, major complications and in-hospital mortality. Methods: From January 2012 until November 2012, 40 patients with LVEF ≥50%, EuroSCORE II